Cargando…

Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis

The current evidence-base for recommendations on the treatment of cutaneous leishmaniasis (CL) is generally weak. Systematic reviews have pointed to a general lack of standardization of methods for the conduct and analysis of clinical trials of CL, compounded with poor overall quality of several tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olliaro, Piero, Vaillant, Michel, Arana, Byron, Grogl, Max, Modabber, Farrokh, Magill, Alan, Lapujade, Olivier, Buffet, Pierre, Alvar, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605149/ https://www.ncbi.nlm.nih.gov/pubmed/23556016 http://dx.doi.org/10.1371/journal.pntd.0002130

Ejemplares similares

Using a consensus technique for improving the methodology of clinical trials assessing treatments for Cutaneous Leishmaniasis
por: Erber, Astrid, et al.
Publicado: (2015)

Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006
por: Modabber, Farrokh, et al.
Publicado: (2007)

Harmonized clinical trial methodologies for localized cutaneous leishmaniasis and potential for extensive network with capacities for clinical evaluation
por: Olliaro, Piero, et al.
Publicado: (2018)

A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
por: Mears, Emily Rose, et al.
Publicado: (2015)

CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis
por: Thacker, Seth G, et al.
Publicado: (2020)

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review
por: Hirve, Siddhivinayak, et al.
Publicado: (2016)

Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers
por: Mouri, Oussama, et al.
Publicado: (2023)

Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis
por: Ghalib, Hashim, et al.
Publicado: (2007)

Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis
por: Caridha, Diana, et al.
Publicado: (2019)

Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study
por: Erber, Astrid C., et al.
Publicado: (2020)

Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
por: Zijlstra, Eduard E., et al.
Publicado: (2017)

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

Towards elimination of visceral leishmaniasis in the Indian subcontinent—Translating research to practice to public health
por: Hirve, Siddhivinayak, et al.
Publicado: (2017)

An international qualitative study exploring patients’ experiences of cutaneous leishmaniasis: study set-up and protocol
por: Erber, Astrid Christine, et al.
Publicado: (2018)

Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs
por: Vaillant, Michel, et al.
Publicado: (2007)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

A Comprehensive Review of Cutaneous Leishmaniasis in Kerman Province, Southeastern Iran-Narrative Review Article
por: SHARIFI, Iraj, et al.
Publicado: (2015)

Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness
por: Olliaro, Piero L., et al.
Publicado: (2019)

WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study
por: Ben Salah, Afif, et al.
Publicado: (2009)

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
por: Olliaro, Piero, et al.
Publicado: (2021)

COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply
por: Olliaro, Piero, et al.
Publicado: (2021)

Anti-malarial drug safety information obtained through routine monitoring in a rural district of South-Western Senegal
por: Brasseur, Philippe, et al.
Publicado: (2012)

Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
por: Sundar, Shyam, et al.
Publicado: (2007)

Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis
por: Fortin, Anny, et al.
Publicado: (2014)

Long COVID: aiming for a consensus
por: Munblit, Daniel, et al.
Publicado: (2022)

Evaluation of a diagnostic device, CL Detect rapid test for the diagnosis of new world cutaneous leishmaniasis in Peru
por: Grogl, Max, et al.
Publicado: (2023)

More Efficient Ways of Assessing Treatments for Neglected Tropical Diseases Are Required: Innovative Study Designs, New Endpoints, and Markers of Effects
por: Olliaro, Piero, et al.
Publicado: (2012)

Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama
por: Sosa, Néstor, et al.
Publicado: (2013)

Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform
por: Bush, Jacob T., et al.
Publicado: (2017)

A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
por: López, Liliana, et al.
Publicado: (2018)

Cutaneous leishmaniasis mimicking cutaneous lymphoma
por: Pires, Carla Andréa Avelar, et al.
Publicado: (2019)

Unusual Presentation of Cutaneous Leishmaniasis: Ocular Leishmaniasis
por: Doroodgar, Masoud, et al.
Publicado: (2017)

Recurrent cutaneous leishmaniasis*
por: Gomes, Ciro Martins, et al.
Publicado: (2013)

Zosteriform cutaneous leishmaniasis
por: Tin, Sim Sai, et al.
Publicado: (2014)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal
por: Olliaro, Piero L, et al.
Publicado: (2008)

Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
por: Bern, Caryn, et al.
Publicado: (2008)

Plurifocal cutaneous leishmaniasis during treatment with ustekinumab
por: Rakotonarivo, Louva, et al.
Publicado: (2018)

Psycho-social impacts, experiences and perspectives of patients with Cutaneous Leishmaniasis regarding treatment options and case management: An exploratory qualitative study in Tunisia
por: Boukthir, Aicha, et al.
Publicado: (2020)

Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis
por: Shio, Marina Temi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hlif561rnhtl4tbkgkv5s37qlp